we observed the following : clonogenic breast tumor cells were more sensitive to 4-hydroperoxy-cyclophosphamide ( a metabolite of cyclophosphamide with in vitro activity ) than to 5-fluorouracil and to doxorubicin ( the other two agents used in the frontline treatment of breast carcinoma ) .
C1458155
breast tumor
C0010583
cyclophosphamide